Secondaries Announced 6.20.16 – Postmarket
IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Medgenics, Inc. Symbol: MDGN Price: Last Trade $6.25 Description: Re-offer Range: $5.50-$5.75 Trade Date: 6/21 Shares: 3.6 million Underwriter(s) Jefferies Co-Managers: […]